Dextran 40 therapy made safer by pretreatment with dextran 1.
Ljungström
Karl-Gösta
KG
Stockholm, Sweden.
D000707:Anaphylaxis / Q000139:chemically induced / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D003911:Dextrans / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry* / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D011292:Premedication / Q000379:methods*; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D013329:Structure-Activity Relationship; D016019:Survival Analysis
D003911:Dextrans